 The decades-long quest to develop a HIV vaccine has been dealt another major blow, with the last true candidate in development failing to prevent infections any better than a placebo in late-stage clinical trials. The multinational Mosaico study, which began in 2019 and involved more than 3,900 volunteers, was investigating a four-shot HIV vaccine for ... Major Blow as Experimental HIV Vaccine Fails in Late Clinical... 